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Background: To estimate rheumatoid arthritis (RA) prevalence in Quebec using administrative health data,
comparing across regions.
Methods: Cases of RA were ascertained from physician billing and hospitalization data, 1992–2008. We used
three case definitions: 1) ≥ 2 billing diagnoses, submitted by any physician, ≥ 2 months apart, but within 2 years;
2) ≥ 1 diagnosis, by a rheumatologist; 3) ≥1 hospitalization diagnosis (all based on ICD-9 code 714, and ICD-10
code M05). We combined data across these three case definitions, using Bayesian hierarchical latent class models
to estimate RA prevalence, adjusting for the imperfect sensitivity and specificity of the data. We compared urban
versus rural regions.
Results: Using our case definitions and no adjustment for error, we defined 75,760 cases for an over-all RA prevalence
of 9.9 per thousand residents. After adjusting for the imperfect sensitivity and specificity of our case definition algorithms,
we estimated Quebec RA prevalence at 5.6 per 1000 females and 4.1 per 1000 males. The adjusted RA prevalence
estimates for older females were the highest for any demographic group (9.9 cases per 1,000), and were similar in
rural and urban regions. In younger males and females, and in older males, RA prevalence estimates were lower
in rural versus urban areas.
Conclusions: Without adjustment for error inherent in administrative databases, RA prevalence in Quebec was
approximately 1%, while adjusted estimates are approximately half that. The lower prevalence in rural areas, seen
for most demographic groups, may suggest either true regional variations in RA risk, or under-ascertainment of
cases in rural Quebec.
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There is growing interest in developing tools and
methods for the surveillance of chronic rheumatic dis-
eases, using existing resources such as administrative
health databases. Comparing disease prevalence across
certain regions might be of particular interest; for ex-
ample, for historic and geographic reasons, individuals
in some rural regions of Quebec have been somewhat
isolated from other parts of the province. This has many
potential effects; one may be differences in genetic
make-up, and other may be variations in access to care.
Differences in access to care might mean that the* Correspondence: sasha.bernatsky@mcgill.ca
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case definitions may vary across rural versus urban
areas, and even within rural areas, from one sub-region
to another.
Our objective was to estimate the prevalence of
rheumatoid arthritis (RA) in Quebec based on adminis-
trative health data, and to determine if RA prevalence
estimates were any different in urban versus rural re-
gions. We also performed exploratory sub-analyses in
two regions which have been particularly isolated geo-
graphically. Since administrative data rely on medical
contact in order to ascertain cases, the RA prevalence
estimates in these very isolated areas (where access to
care is presumably lower) might be different from the
rest of rural Quebec. On the other hand, very isolated
regions generally tend to have reduced genetic variation
[1-3] which theoretically could alter RA risk (comparedral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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risk factor (albeit a complex one) for RA [4]. We sought
to provide new data regarding the estimates of RA
prevalence across regions in Quebec, including these
very isolated regions. The methodological approach
chosen in this paper offers a means of dealing with the
imperfect nature of administrative data, as will be seen.
Methods
We used hospitalization and physician billing data for all
of Quebec (approximately 7.6 million residents), across
1992–2008, to estimate the prevalence of existing RA
cases in 2008. The data include hospitalization discharge
diagnoses (a primary diagnosis and 15 non-primary diag-
noses per hospitalization, abstracted by medical records
clerks) and physician visit billing claim diagnostic codes
(a single diagnostic code is allowed per visit). All, diag-
noses are provided as International Classification of
Diseases (ICD-9 and ICD-10) codes (RA being repre-
sented by ICD-9 code 714, and ICD-10 code M05). In
the hospitalization data, we defined a potential RA case
as any hospitalization that included RA as a primary or
non-primary discharge diagnosis. In the billing data,
potential cases were required to have 2 or more RA
diagnostic codes (by any physician) at least 2 months
apart but within a 2-year span. A second alternative algo-
rithm defined a potential case on the basis of at least one
RA diagnostic code during a visit to a rheumatologist.
Cases aged <18 were not excluded. Deceased residents are
recorded by Quebec vital statistics and the information
provided with the linked administrative data.
Once potential RA cases in Quebec were identified by
one or more of these case definitions, we used our previ-
ously developed Bayesian latent class hierarchical models
to generate prevalence estimates from these data, adjust-
ing for the imperfect sensitivity and specificity of these
sources [5,6]. This approach does not rely on a gold
standard (which is unavailable in these administrative
data). Instead, multiple case definitions each provide
some information about the case status of subjects. This
allows the disease status for each subject to be estimated
probabilistically, and the sum of these probabilities pro-
vides the number of estimated cases. The sensitivity and
specificity estimates produced from this model are rela-
tive to the true disease status of subjects, which is not
known and is thus a ‘latent’ variable. This allows simul-
taneous estimation of disease prevalence, as well as the
sensitivity and specificity of each case definition [7].
Bayesian methods use probability distributions to reflect
uncertainty about parameters in a model [8]. One begins
with a ‘prior distribution’ which may be ‘uninformative’
(where the results will thus be ‘informed’ mainly by the
data) or ‘informative’ (which describe likely starting
values for a parameter of interest). Our Bayesian latentclass model accounted for possible conditional depend-
ence between our ascertainment methods, that is, the
possibility that the ascertainment methods are dependent
even conditional on the (unknown) true case status. This
model is non-identifiable without informative prior input
on at least two parameters. Based on previous work on
rheumatic disease case ascertainment using administrative
data [9], we expected the specificities of all methods to be
very high. Therefore, for our primary analyses we set in-
formative prior distributions for the specificities of our
three case ascertainment approaches. This prior distribu-
tion corresponds to specificities of 98% (potential values
ranging from approximately 96–100%). This choice was
based on our early work in systemic autoimmune rheum-
atic disease [10] and is supported by data from a recent
validation study of administrative data which suggest that
algorithms that incorporate RA billing data have a specifi-
city of 99-100% [11].
We constructed 95% credible intervals (95% CrI) repre-
senting the values between which there is a 95% probabil-
ity of containing the parameter of interest, given the data
and the prior information used. All programming was car-
ried out using WinBUGS software (MRC Biostatistics
Unit, University of Cambridge, Cambridge, UK).
Since RA prevalence is known to vary according to age
and sex, we derived age and sex-specific estimates, based
on the demographic data found in the administrative data
sources. Information on region of residence was based on
the forward sortation area information for subjects (that
is, the first three digits of an individual’s Canadian postal
code) which is available in the health care administrative
database. We calculated period prevalence based on the
estimated number of cases ascertained over 1992–2008,
using census statistics to determine the appropriate popu-
lation denominator and the group-specific prevalence per
100,000 residents. The hierarchical nature of our Bayesian
latent class model allowed for differences in sensitivity of
the different three case definitions in capturing RA within
populations defined by sex, age group, and residence.
Two sub-regions of rural Quebec for which we pro-
duced specific estimates of RA prevalence included Les
Îles de la Madeleine (in the Gulf of Saint Lawrence), and
the Saguenay/Lac-St-Jean census metropolitan area, in the
northern-east part of Quebec. Les Îles de la Madeleine
form a small archipelago in the Gulf of Saint Lawrence
with a land area of 205.53 square kilometres, forming a
census division and a three-digit postal code region
(G4T). There are 8 major islands, all but one inhabited,
but only two municipalities, Les Îles-de-la-Madeleine
(2006 census pop. 12,560), and Grosse-Île (pop. 531). The
Saguenay-Lac-St-Jean region is located in the northern-
eastern part of Quebec, and the vast majority of its popu-
lation is of French-Canadian descent, with a unique and
relatively limited genetic pool. The region has remained
Table 1 Rheumatoid arthritis in rural and urban Quebec:
Period prevalence (1992–2008) estimates (per 1,000
residents) according to age and sex categories, based on






Rural Female 45+ 9.95 9.94, 9.95
Female < 45 1.53 1.44, 1.62
Male 45+ 7.45 7.20, 7.70
Male < 45 0.47 0.43, 0.52
Urban Female 45+ 9.95 9.95, 9.95
Female < 45 2.05 1.97, 2.13
Male 45+ 9.94 9.90, 9.95
Male < 45 0.73 0.68, 0.78
*Bayesian 95% credible intervals the values between which there is a 95%
probability of containing the parameter of interest, given the data and the
prior information used.
Table 2 Rheumatoid arthritis in over-all rural Quebec and
in two rural sub-regions: Period prevalence (1992–2008)
estimates (per 1,000 residents) according to age and sex
categories, based on latent class model regression:






Rural Quebec* Female 45+ 9.95 9.94 9.95
Female < 45 y/o 1.53 1.44 1.62
Male 45+ 7.45 7.20 7.70
Male < 45 y/o 0.47 0.43 0.52
Iles de la Madeleine Female 45+ 9.65 9.00 9.94
Female < 45 y/o 4.00 2.00 7.22
Male 45+ 7.17 4.24 9.71
Male < 45 y/o 0.37 0.00 2.10
Saguenay Female45+ 9.90 9.68 9.95
Female < 45 y/o 2.30 1.77 2.99
Male 45+ 5.50 4.45 6.80
Male < 45 y/o 0.60 0.38 0.99
*Estimate for rural Quebec does not include the two sub-regions.
**Bayesian 95% credible intervals the values between which there is a 95%
probability of containing the parameter of interest, given the data and the
prior information used.
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tion size of approximately 285,000 individuals.
Rheumatology access in these two regions has been
problematic for some time. From 1990 to 2000, rheuma-
tologists from Quebec City travelled 2–3 days a month
to Saguenay/Lac-St-Jean to see patients. After this, pa-
tients from the Saguenay/Lac-St-Jean region travelled to
Quebec City to see rheumatologists. A single rheuma-
tologist began to work in Saguenay/Lac St-Jean only
after the end date of our study interval. Similarly, one
rheumatologist from Quebec City travels to Iles de la
Madeleine three times a year, to conduct one week of
clinic, but this is a more recent practice. For the period
of our observation interval, most RA patients from Îles
de la Madeleine were followed by local generalist physi-
cians. Our study was approved by the McGill University
research ethics board, without requirement for consent,
as we did not have direct access to patients, or nominal
information.
Results
Using our case definitions and no adjustment for error,
we defined 75,760 individuals who met one or more of
the RA definitions at least once from 1992 onward, and
remained alive up to 2008. This number translates into
unadjusted estimates of an over-all RA prevalence of 9.9
per thousand residents. With these case definitions and
no adjustment for error, we defined 139 RA cases in
13,110 individuals, (representing an over-all prevalence
of 10.6/1000) in Iles de la Madeleine. In Saguenay/Lac-
St-Jean, we defined 1,094 RA cases in 138,671 residents
(7.9/1000). In the rest of Quebec, this algorithm defined
74,527 cases, within a population of 7,464,237 (10.0/
1000).
Our Bayesian hierarchical latent class model estimates,
adjusting for the imperfect sensitivity and specificity of
our case definition algorithms, suggested a Quebec RA
prevalence of 4.83 cases per 1,000 persons (95% CrI
4.80, 4.86). As expected, the prevalence estimate was
higher in females at 5.57 per 1000 (95% CrI 5.54, 5.60)
versus males (4.06 per 1000; 95% CrI 4.01, 4.11).
The results from our Bayesian model, stratified by resi-
dence and age/sex groups, are indicated in Table 1. RA
prevalence estimates for older females were identical in
rural and urban regions. However, RA prevalence esti-
mates tended to be lower in rural versus urban regions for
all other age-sex groups. Generally, estimates of RA preva-
lence were considerably higher in older versus younger in-
dividuals. This is to be expected, since RA is a chronic
disease with onset occurring in working force age and
older. In younger individuals, RA prevalence estimates
were clearly higher for females versus males, which again
reflects the known female-predominance of RA during
young adulthood, with a diminishing difference in thefemale: male ratio in older age groups. The highest preva-
lence was in older urban residents, where RA prevalence
was about 9.9 cases per 1,000 (essentially 1%).
Table 2 displays the prevalence estimates for age and sex
specific strata in the regions of both Îles de la Madeleine
and Saguenay, compared to over-all Quebec rural rates. In
older individuals, the prevalence estimates for both males
and females were similar to the over-all rural RA preva-
lence estimates for these demographic groups. In addition,
within the bounds of the credible intervals, the estimates
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identical) in the regions of both Saguenay/Lac-St-Jean and
Iles de la Madeleine, compared to the over-all rural RA
prevalence estimates for these demographic groups. How-
ever, in both sub-regions of Saguenay/Lac-St-Jean and Iles
de la Madeleine, RA prevalence for younger women was
estimated as slightly higher, than the over-all Quebec rural
estimate for this demographic group.
Figure 1 shows the sensitivity estimates for the differ-
ent case definitions, according to age and sex categories,
for rural versus urban residence. In both regions, the
algorithm based on two physician billing codes was esti-
mated to be the most sensitive of the three case defini-
tions, across all age and sex groups. Both case definitions
that used billing data tended to be more sensitive in youn-
ger (versus older residents). This was more pronounced
for the algorithm based on one or more rheumatology bill-
ing code for RA, particularly in rural areas. This figure is
interesting in that it could suggest that individuals older
than 45 are less likely to be seen by rheumatologists in
rural, than in urban, areas. As might be expected, the
sensitivity of hospitalization diagnoses for RA caseFigure 1 Sensitivity estimates for the different case definitions based
rheumatoid arthritis (RA), within administrative data: Variations in urb
*2 billing codes by any physician for RA, at least 8 weeks apart but within 2
both primary and non-primary discharge diagnoses (up to 15). At least oneascertainment was low (since most RA patients would not
be hospitalized).
Discussion
Although a vast majority of the land area in Quebec is
rural, twenty percent of Quebec residents live in rural
areas. Of these twenty percent, 7% live on farms and the
remaining 93% live in small towns. Many rural areas, in-
cluding the Lac St. Jean and Iles des Madeline regions,
are predominantly French-speaking, although in some re-
gions, particularly northern regions, first-nations groups
are represented. The population of Quebec’s rural com-
munities as a whole includes slightly more children (below
age 15) and seniors (age 65 and over) than Quebec’s urban
areas. Employment conditions, incomes, and education
levels are all far better in urban areas. The further the dis-
tance from the large centres, the more these economic
characteristics generally deteriorate [12].
Without adjustment for error inherent in administra-
tive databases, RA prevalence in Quebec was approxi-
mately 1%, while adjusted estimates are approximately
half that. In comparison, using administrative databaseson International Classification of Diseases (ICD) codes for
an versus rural residence, according to age and sex groups.
years. One or more hospital discharge diagnoses for RA, including,
billing code for RA by a rheumatologist.
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and sex standardized RA prevalence estimates in Ontario
from 1996–2010 have been estimated at 0.5%-0.9% [13].
Our results suggested that prevalence estimates tended
to be lower in rural versus urban areas, for most demo-
graphic groups (although the prevalence estimates for
older females were identical between rural and urban re-
gions). We found that RA prevalence estimates in two
rural regions (Îles de la Madeleine and Saguenay-Lac-St-
Jean) were similar to the over-all estimates for rural
Quebec. This was in contrast to our suspicion that these
areas, being more remote than the rest of rural Quebec,
might have less access to medical care, and subsequently
lower RA prevalence estimates based on administrative
data. The one difference was observed in younger
women from these two sub-regions, who had higher RA
prevalence estimates than in the rest of Quebec. Our re-
sults therefore do not preclude the possibility of some
genetic predisposition (or other risk factor) driving RA
prevalence in these areas.
Most data from the developed world suggest RA
prevalence estimates between 0.5% and 1%; our estimate
of over-all RA prevalence in Quebec is at the lower end
of this spectrum, which could be related to various fac-
tors. First, published estimates vary greatly in terms of
methods; additionally, it has been suggested that there is
a trend for a slight decrease in RA prevalence over the
past several decades. A study from Rochester, Minnesota
showed a prevalence of clinically confirmed RA in 1985
to be 1.07% (95% confidence interval [95% CI] 0.94–
1.20) among adults aged >35 years of age; using the
same methods, the estimate of RA prevalence fell to
0.85% in 1995 (95% CI 0.75–0.95) [14]. More recent data
suggest an RA prevalence in the US of about 0.6% [15],
which is similar to our own adjusted estimate.
Our estimates of the sensitivity of the different case
definitions suggest that without the case definition cap-
turing two physician visits for RA, prevalence would in-
deed be under-estimated, particularly in rural areas.
That is, at least in Quebec, case definitions based on
rheumatologist billing alone, will likely miss proportion-
ally more RA in rural, than in urban, areas. This could
lead to falsely low estimates of RA prevalence in rural
areas. An approach similar to ours, which combines
more than one case definition, and adjusts for imperfect
specificity and sensitivity, may then be more useful than
reliance on a single case definition.
Although rheumatology care is indeed scarce in the
Saguenay/Lac St. Jean and Iles-de-la Madeleine regions,
there are issues in other parts of the province as well; in
fact there are no rheumatologists located in the large ex-
panses of Cote Nord (which encompasses much of the
northern shore of the Saint Lawrence River estuary and
the Gulf of Saint Lawrence) and Nord du Quebec (whichcovers most of the Labrador Peninsula) [16]. Based on
Canadian Medical Association (CMA) statistics for the
distribution of rheumatologists, Quebec has been slightly
above the Canadian average of 1.01 rheumatologists per
100,000 residents [17]. This observation is limited by the
fact that CMA statistics for the number of rheumatolo-
gists in Canada may not actually reflect active practice, ac-
counting for the number of part-time versus full-time
rheumatologists or their academic versus clinical practice.
Potential limitations of our study relate to the fact that
RA cases were not clinically validated, and that the data
reflect only persons seeking medical care, who are given
an RA diagnosis on billing or hospitalization data. More-
over, physicians can only provide one billing diagnosis
per visit, and physicians not infrequently assign diagnos-
tic codes even prior to confirming a diagnosis [18].
The requirement of ‘2 or more physicians billing diag-
noses, at least 2 months apart and within a 2 year span’
reflects modelled after an early administrative data-
based algorithm first presented by Maclean et al. [19]
and modified for use by others [20,21]. This approach
has also been used by other chronic disease researcher
(e.g. for diabetes research and surveillance) and is based
on the knowledge that a single billing code lacks specifi-
city (in RA, one validation study suggested a specificity
of only 62.5%) [11,22]. Our approach disregards codes
that are close in time (less than 2 months) since presum-
ably a significant proportion of those represent follow-
up visits where the diagnosis is being ruled out. [18] At
the same time, it is presumed that there should be no
more than a 2 year period between codes, since a longer
period might make it unlikely that the subject truly has
the disease in question.
In fact, the Public Health Agency of Canada includes
similar case definition in their surveillance definitions,
and across all provinces, it functions well in terms of
providing reasonable and stable estimates of disease
prevalence [23]. Of course, there have been some studies
using 3 or more billing diagnoses (Shipton et al.) [24]
and a recent validation study in Canada confirmed pres-
ervation of sensitivity (83%) and accuracy (81-82%). [11]
The validation study showed moreover that increasing
the stringency of the algorithm, such as by limiting cases
to those only with rheumatology billing code diagnoses,
actually decreased accuracy (78%) [11].
We used Bayesian latent class regression to combine in-
formation from different case definitions, and based on
our earlier experience with this approach, and the use of
multiple sources of administrative data for rheumatic case
identification, we assigned high prior values for specificity
of the billing code algorithms. Though there have been
some recent validation studies which found specificities
that were somewhat lower [22] for physician-billing algo-
rithms, these were not population-based studies, but
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a rheumatologist diagnosis and the validation samples
were only selected from rheumatology offices, not the
general population. The one available study that was
population-based, using administrative data case defini-
tions similar to ours (with case validation done via chart
review of unselected family medicine records, not
rheumatology clinics) found that the specificity of phys-
ician billing case definition algorithms were 97% [11].
RA is more common among women than men, par-
ticularly during reproductive years. In our analyses, the
estimated prevalence among men age 45 and older was
only slightly lower than that of women in this age group.
In fact, similar trends have been noted in an epidemio-
logic study in Ontario, [13] representing an established
tendency for the female-to-male ratio in RA, to diminish
in older age. Since RA prevalence also increases steeply
with age, in the categories of age 45 and older, a very
considerable number of the cases in this subgroup are
likely to be seniors (between age 65 and 85), a demo-
graphic where males and females have more similar RA
risk, than in younger individuals [25]. Our Bayesian ap-
proach did allow us to estimate sensitivity differences ac-
cording to sex, and as indicated in our figure (which
importantly, also considers potential differences in sensi-
tivity across sex and urban–rural groups), our estimates
of sensitivity for the algorithms did not appear to be par-
ticularly affected by sex. As mentioned in the introduction,
previous work on rheumatic disease case ascertainment
using administrative data had estimated that the specific-
ities of all methods as very high, and these did not differ by
sex [9].
Finally it should be noted that our intent was to pro-
vide an RA prevalence estimate based on the whole
population of interest, without focussing on, or exclud-
ing, pediatric-onset RA or juvenile idiopathic arthritis
(JIA). Cases aged <18 represent only a small component
of the RA billing codes; in pediatrics JIA includes some
entities that one might consider more in keeping with
the concept of ‘juvenile rheumatoid arthritis’ and others
where the adult counterpart (more or less) includes
what, in adults, is considered “sero-negative arthritis”,
not RA. That being said, we have actually been working
with the PHAC and members of the Canadian Alliance
of Pediatric Rheumatology Investigators (CAPRI) to de-
velop an alternative approach to the JIA case definition,
which incorporate a wider range of ICD codes (i.e. to in-
clude juvenile-onset seronegative arthopathies).
Conclusions
On one hand, our results are of considerable interest, in
that the effects of poor access to medical care in more
remote areas may not be as dramatic as has been feared.
This is somewhat re-assuring, given recent efforts on thepart of the Public Health Agency of Canada to use ad-
ministrative data for chronic disease surveillance [26].
On the other hand, the results do not rule out poor ac-
cess to rheumatology care across all of rural Quebec.
We cannot under-estimate the potential public health
problem resulting from this. Thus, caution must still be
exercised in the interpretation of prevalence estimates
based on these data, and further attempts should be
made to optimize the methodological approaches using
administrative data for rheumatic disease research and
surveillance [27].
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